Get the Stockscreener App
33.82
3.93%
1.28
Oscar Health Inc stock is traded at $33.82, with a volume of 1.58M.
It is up +3.93% in the last 24 hours and up +5.26% over the past month.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
See More
Previous Close:
$32.54
Open:
$32.78
24h Volume:
1.58M
Relative Volume:
0.31
Market Cap:
$10.44B
Revenue:
$13.30B
Net Income/Loss:
$-39.39M
P/E Ratio:
-55.48
EPS:
-0.6096
Net Cash Flow:
$2.80B
1W Performance:
+0.09%
1M Performance:
+5.26%
6M Performance:
+105.78%
1Y Performance:
+67.59%
1-Day Range:
$32.64
$33.88
1-Week Range:
$31.65
$34.52
52-Week Range:
$10.69
$35.01
Oscar Health Inc Stock (OSCR) Company Profile
Name
Oscar Health Inc
Sector
Industry
Phone
(646) 403-3677
Address
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSCR
Oscar Health Inc
|
33.82 | 10.44B | 13.30B | -39.39M | 2.80B | -0.6096 |
UNH
Unitedhealth Group Inc
|
422.10 | 378.87B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.62 | 121.02B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
440.59 | 95.55B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
306.31 | 80.94B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
429.20 | 51.54B | 137.20B | 1.15B | 1.27B | 9.3439 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-04-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-06-26 | Initiated | Wolfe Research | Peer Perform |
| Apr-20-26 | Upgrade | Jefferies | Underperform → Hold |
| Feb-12-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-09-26 | Upgrade | UBS | Sell → Neutral |
| Jan-05-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Initiated | Stephens | Equal-Weight |
| Nov-26-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-15-25 | Downgrade | UBS | Neutral → Sell |
| Jul-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-02-25 | Initiated | Barclays | Underweight |
| Jun-24-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-24 | Initiated | Jefferies | Underperform |
| Nov-06-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-07-24 | Initiated | UBS | Neutral |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-22-24 | Initiated | Raymond James | Outperform |
| Nov-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-14-22 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-14-21 | Initiated | Goldman | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Mar-30-21 | Initiated | Wells Fargo | Overweight |
| Mar-29-21 | Initiated | BofA Securities | Buy |
| Mar-29-21 | Initiated | Cowen | Market Perform |
| Mar-29-21 | Initiated | Credit Suisse | Outperform |
| Mar-29-21 | Initiated | Goldman | Buy |
| Mar-29-21 | Initiated | Morgan Stanley | Overweight |
View All
Oscar Health Inc Stock (OSCR) Latest News
Oscar Health Expands Into South Carolina for 2027 - GuruFocus
Oscar Health Expands to South Carolina; Launches RetireEase Plan - marketscreener.com
Oscar Health expands to 21 states, adds South Carolina market By Investing.com - Investing.com Canada
Oscar Health unveils 2027 insurance plans, enters South Carolina - StreetInsider
Oscar Introduces a New Wave of Consumer Health Products - 巴士的報
Oscar Introduces a New Wave of Consumer Health Products | Associated Press | syndication news - Enidnews.com
Oscar Introduces a New Wave of Consumer Health Products - Morningstar
As Rivals Retreat, Oscar Health Plans To Expand Obamacare For 2027 - Yahoo Finance
3 Big Reasons to Love Oscar Health (OSCR) - TradingView
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know - Yahoo Finance
Oscar Health, Inc. $OSCR Stock: Assenagon Asset Management S.A. Increases Position - MarketBeat
Oscar Health, Inc. (OSCR) Options Chain - Yahoo! Finance Canada
Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy? - Zacks Investment Research
Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy? - Yahoo Finance UK
Are Finance Stocks Lagging ASX LimitedUnsponsored ADR (ASXFY) This Year? - Zacks Investment Research
Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and Heico - Zacks Investment Research
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why - Zacks Investment Research
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
3 Top Ranked Stocks Gaining Despite Market Turmoil - Zacks Investment Research
Oscar Health: 7X The Revenue Since Its IPO, And A Rerating Due In 2027 (NYSE:OSCR) - Seeking Alpha
Best Growth Stocks to Buy for October 15th - Zacks Investment Research
Fresh Catalysts Put OSCR, PNGAF and GME in Focus - SECFilings.com
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts - Zacks Investment Research
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Health insurance market contracts as Obamacare subsidies end - Seeking Alpha
Oscar Health, Inc. (OSCR) is a Top-Ranked Momentum Stock: Should You Buy? - Zacks Investment Research
This Top Finance Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Zacks Investment Research
Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors - Zacks Investment Research
Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors - Yahoo Finance
Oscar Health: The Insurer That Grows as Obamacare Shrinks - marketscreener.com
Oscar Health (OSCR) Could Be 94% Undervalued Following Raised Earnings Estimates - Yahoo Finance
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Zacks Investment Research
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Zacks Investment Research
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Yahoo Finance
Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich? - Zacks Investment Research
Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich? - Yahoo Finance
Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going? - Zacks Investment Research
Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going? - Yahoo Finance
Why Is Oscar Health (NYSE:OSCR) Reaching New Highs? - Kalkine Media
Aon Expands Ukraine War Risk Insurance Facility With EBRD Support - Zacks Investment Research
Oscar Health (NYSE:OSCR) Sets New 12-Month HighHere's What Happened - MarketBeat
Oscar Health stock hits 52-week high at 34.5 USD - Investing.com
Oscar Health stock hits 52-week high at 34.5 USD By Investing.com - Investing.com India
Best Growth Stocks to Buy for October 13th - Zacks Investment Research
OSCR Maintained by UBS -- Price Target Raised to $36 - GuruFocus
Oscar Health's Q3 Upside Less Certain as Guidance Reflects Positive Trends, UBS Says - marketscreener.com
Financials Sector Declines in Q3 2026 as Oscar Health (OSCR) Sho - GuruFocus
Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call - Business Wire
Oscar Health, Inc. (OSCR) options chain - Yahoo Finance UK
Global Insurtech Market Size, Share, Trends, and Forecast to 2035 | AI, Cloud, and Automation Drive 41.45% CAGR, Creating a USD 638 Billion Opportunity - GlobeNewswire Inc.
Oscar Health Inc Stock (OSCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oscar Health Inc Stock (OSCR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WITTMAN VANESSA AMES | Officer |
Sep 18 '26 |
Proposed Sale |
32.24 |
25,000 |
806,000 |
0 |
| Liang Janet | President, Oscar Insurance |
Sep 03 '26 |
Sale |
31.45 |
10,360 |
325,822 |
248,697 |
| Blackley Richard Scott | Chief Financial Officer |
Sep 03 '26 |
Sale |
31.45 |
28,869 |
907,930 |
1,046,108 |
| McAnaney Adam | Chief Legal Officer |
Sep 03 '26 |
Sale |
31.45 |
9,092 |
285,943 |
209,004 |
| Schlosser Mario | Director |
Sep 03 '26 |
Sale |
31.45 |
31,422 |
988,222 |
449,444 |
| McAnaney Adam | Officer |
Sep 03 '26 |
Proposed Sale |
31.45 |
9,092 |
285,950 |
0 |
| Schlosser Mario | Officer |
Sep 03 '26 |
Proposed Sale |
31.45 |
31,422 |
988,244 |
0 |
| Liang Janet | Officer |
Sep 03 '26 |
Proposed Sale |
31.45 |
10,360 |
325,829 |
0 |
| Blackley Richard Scott | Officer |
Sep 03 '26 |
Proposed Sale |
31.45 |
28,869 |
907,950 |
0 |
| Baltrus Victoria | Chief Accounting Officer |
Sep 03 '26 |
Sale |
31.45 |
958 |
30,129 |
213,631 |
4.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):